CRISPR Therapeutics AG

CRISPR Therapeutics develops medicines by editing human genes to treat serious diseases. The company uses a technology called CRISPR/Cas9 that can precisely change the genetic code in a patient's cells to fix disease-causing mutations. Their main product, CASGEVY, treats blood disorders like sickle cell disease and beta-thalassemia by editing patients' blood cells to produce more healthy hemoglobin. The company is also working on treatments for cancer, autoimmune diseases, and heart disease using similar gene-editing techniques.